Homeopathic treatments modify inflammation but not behavioral response to influenza antigen challenge in BALB/c mice

Background: Influenza affects thousands of people worldwide every year, motivating the development of new therapies. In this work, the effects of two homeopathic preparations (influenza biotherapies and thymulin) were chosen following two different rationales: isotherapy and endo-isotherapy models. The homeopathic effects were evaluated individually considering the inflammatory and behavioral responses against influenza virus antigen were studied in BALB/c mice.

Methods: Male adult mice were treated orally and blindly for 21 days with highly diluted influenza virus or with thymulin, and were divided in two sets of experiments. The first series of experiments aimed to describe their behavior, using an open field (OF) device. In the second series, mice were challenged subcutaneously with influenza hemagglutinin antigen (7 μg/200 μl) at day 21. At day 42, behavior and inflammation response were evaluated.

Results: No behavioral changes were seen in OF tests at any time point after treatments. Flow cytometry and morphometry revealed significant changes in T and B cell balance after influenza antigen challenge, varying according to treatment.

Conclusion: The results show that both homeopathic treatments induced subtle changes in acquired immune anti-viral response regulation. A deeper understanding of the mechanism could elucidate their possible use in influenza epidemiological situations.

Keywords

Homeopathy - Influenza virus - Influenza hemagglutinin antigen - Behavior - Thymulin - Immunology

• References

• 1 Kamps BS, Hoffmann C, Preiser W. Influenza Report. Flying Publisher.: 2006.
• 2 Fouchier R.A., Munster V., Wallensten A. et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79 (05) 2005; 2814-2822.
• 3 Palese P. Influenza: old and new threats. Nat Med 10 (12) 2004; S82-S87.
• 4 Oropesa S., Calvi F., Hernández B. et al. Producción de un antisuero específico contra la cepa A/Johannesburg/33/94 (H3N2), y su utilidad en la caracterización de aislamientos de vírus de influenza en ratas Wistar. VacciMonitor 15 (03) 2006; 9-13.
• 5 Imaz S.M., Eimann M., Poyard E., Savy V. Exceso de mortalidad asociada a influenza en Argentina 1992–2002. Rev Chil Infect 23 (04) 2006; 297-306.
• 6 Siqueira C.M. Alterações celulares induzidas por um novo bioterápico do tipo nosódio vivo sobre as linhagens MDCK e J774.G8. Master Thesis 2009. Federal University of Rio de Janeiro, Departamento de Medicamentos.;
• 7 Clausen J., van Wijk R., Albrecht H. Infection models in basic research on homeopathy. Homeopathy 99 2010; 263-270.
• 8 Santana F.R., Coelho C.P., Cardoso T.N., Laurenti M.D., Hurtado E.C.P., Bonamin L.V. Modulation of inflammation response to murine cutaneous Leishmaniosis by homeopathic medicines: thymulin 5cH. Homeopathy 103 2014; 275-284.
• 9 Bonamin L.V., Sato C., Zalla Neto R. et al. Immunomodulations of homeopathic thymulin 5CH in a BCG-induced granuloma model. Evid Based Complement Altern Med 2013. 10.1155/2013/686018.
• 10 Sato C., Listar V.G., Bonamin L.V. Development of broiler chickens after treatment with thymulin 5CH: a zoo technical approach. Homeopathy 101 (01) 2012; 68-73.
• 11 Bastide M., Daurat V., Doucet-Jaboeuf M., Pelegrin A., Dorfman P. Immunomodulatory activity of very low doses of thymulin in mice. Int J Immunother 3 1987; 191-200.
• 12 Siqueira C.M., Costa B.G.B., Amorim A.M. et al. H3N2 homeopathic influenza virus solution modifies cellular and biochemical aspects of MDCK and J774G8 cell lines. Homeopathy 102 2013; 31-40.
• 13 Brazil, Ministério da Saúde. Brazilian homeopathic pharmacopoeia; 3rd edn, 2011.
• 14 Bonamin L.V., Sato C., Neto R.Z. et al. Immunomodulation of Homeopathic Thymulin 5CH in a BCG-induced granuloma model. Evid Based Complement Altern Med 2013. 10.1155/2013/686018.
• 15 Dantas F., Fisher P., Walach H. et al. A systematic review of the quality of homeopathic pathogenetic trials published from 1945 to 1995. Homeopathy 96 2007; 4-16.
• 16 Siqueira C.M., Homsani F., Veiga V.F. et al. Homeopathic medicines for prevention of influenza and acute respiratory tract infections in children: blind, randomized, placebo-controlled clinical trial. Homeopathy 105 2016; 71-77.
• 17 Van Wijk R., Albrecht H. Proving and therapeutic experiments in the HomBRex basic homeopathy research database. Homeopathy 96 2007; 252-257.
• 18 de Paula Coelho C., D’Almeida V., Pedrazzolli-Neto M. et al. Therapeutic and pathogenetic animal models for Dolichos pruriens. Homeopathy 95 2006; 136-143.
• 19 Clausen J., van Wijk R., Albrecht H. Review of the use of high potencies in basic research on homeopathy. Homeopathy 100 2011; 288-292.
• 20 Costa R.A. Homeopathies atualizada. 3rd edn 1988. Ed Vozes; Petropolis: 268.
• 21 Costa R.A. Nosodios vivos. 1st edn 2002. Farmacia Homeopatica Atomo Ltda.; Rio de Janeiro.:
• 22 Lin Y., Zhao Y., Zeng X., Lu C., Liu Y. Genetic and pathobiologic characterization of H3N2 canine influenza viruses isolated in the Jiangsu Province of China in 2009–2010. Vet Microbiol 158 2012; 247-258.
• 23 Varricchio M.C.B.N., Pereira C., Gomes T. Chronic toxicological effects of high diluted solutions of Aveloz (Euphorbia tirucalli L.) on healthy mice: a preliminary study. Int J High Dilution Res 7 2008; 174-178.
• 24 Sato C. Efeitos da timulina 5CH na lesão granulomatosa induzida por BCG: participação de células B-1. Master Thesis 2011. Universidade Paulista.;
• 25 Bot A., Antohi S., Bot S., Garcia-Sastre A., Bona C. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. Int Immunol 9 (11) 1997; 1641-1650.
• 26 Ulmer J.B., Fu T.M., Deck R.R. et al. Protective CD4+ and CD8+T cells against influenza virus induced by vaccination with nucleoprotein DNA. J Virol 72 (07) 1998; 5648-5653.
• 27 Rimmelzwaan G.F., Baars M., van Beek M. et al. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. J Gen Virol 78 1997; 757-765.
• 28 Bender B.S., Tallman E., Johnson M.P., Small Jr. P.A. Enhancement of anti-influenza cytotoxic T lymphocyte activity in senescent mice by vaccination early in life. Vol 55 1990. Elsevier Scientific Publishers Ireland Ltd; 1-7.
• 29 Torres J.V., Wyde P.R., Atassi M.Z. Cytotoxic T lymphocyte recognition sites on influenza virus hemagglutinin. Vol 19 1988. Immunology Letters/Elsevier Science Publishers; 49-54.